SCHEMBL2017894

SCHEMBL2017894

Cc1cc(C(=O)N(C)C(CCNC(=O)c2cccn2C)Cc2ccccc2)c2ccccc2n1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 3/20 0.59
HCRTR2 O43614 2/20 0.59
ALDH1A1 P00352 3/20 0.51
HTT P42858 2/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 1/20 0.46
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 1/20 0.42
CYP2C19 P33261 1/20 0.42
UBE2N P61088 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2052571 1.00 HCRTR1 (0.59) HCRTR1HCRTR2ALDH1A1HTTNPC1
SCHEMBL2013176 0.91 HCRTR1 (0.59) HCRTR1HCRTR2ALDH1A1HTTNPC1
SCHEMBL2013226 0.91 HCRTR1 (0.59) HCRTR1HCRTR2ALDH1A1HTTNPC1
SCHEMBL2011290 0.89 HCRTR1 (0.59) HCRTR1HCRTR2ALDH1A1NPC1RAB9A
SCHEMBL2011288 0.89 HCRTR1 (0.59) HCRTR1HCRTR2ALDH1A1NPC1RAB9A
SCHEMBL2054308 0.87 HCRTR1 (0.60) HCRTR1HCRTR2ALDH1A1NPC1RAB9A
SCHEMBL2011844 0.87 HCRTR1 (0.60) HCRTR1HCRTR2ALDH1A1NPC1RAB9A
SCHEMBL2054318 0.87 HCRTR1 (0.58) HCRTR1HCRTR2ALDH1A1HTTNPC1
SCHEMBL2011240 0.87 HCRTR1 (0.58) HCRTR1HCRTR2ALDH1A1HTTNPC1
SCHEMBL2011910 0.87 HCRTR1 (0.69) HCRTR1HCRTR2ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed